Deeg Mark Albert 4
4 · Regulus Therapeutics Inc. · Filed May 21, 2018
Insider Transaction Report
Form 4
Deeg Mark Albert
Chief Medical Officer
Transactions
- Award
Common Stock (Right to Buy)
2018-05-17+100,000→ 100,000 totalExercise: $0.71Exp: 2028-05-16→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option will vest in forty-eight equal monthly installments, such that the option will be fully vested four years from the date of grant, subject to the Reporting Person's continuous service to us.